How to develop and commercialise digital health solutions

March 2023

After years of record investment and a major leap forward in digital healthcare sparked by the COVID-19 crisis, the tighter market conditions and falling adoption of telehealth sign that enthusiasm for digital health is waning. The pandemic has brought a fundamental change in both the technology infrastructure as well as the mindset of healthcare stakeholders. Both of these will enable the formation of true digital health ecosystems that bring value for patients and healthcare professionals and increase the efficiency of care workflows. To play a full part in the development of these ecosystems, pharma and MedTech leaders face the challenges of developing digital health solutions that meaningfully impact the lives of their users. PwC publishes this report to help pharma and MedTech companies to find the right commercial approach that ensures adoption and sustainable business impact.

Please fill in the form below for downloading "How to develop and commercialise digital health solutions".

Required fields are marked with an asterisk(*)

Email address*

Re-type Email address

Salutation

Mrs

Name*

Company/organisation*

Department

Position

Note

By submitting this form, you confirm you have read our Privacy Statement (https://www.pwccn.com/en/privacy.html) and explicitly consent to the processing of personal information as set out in the Privacy Statement (including international transfers). PwC may rely on other legal grounds of processing to the extent permitted under applicable law.

By clicking the box, you agree PwC China (including Hong Kong) may, from time to time, send you material relevant to your interests. You may opt out of receiving marketing materials from us at any time at https://www.pwccn.com/en/unsubscribe.html.

By submitting this form, you confirm you have read our Privacy Statement and explicitly consent to the processing of personal information as set out in the Privacy Statement (including international transfers). PwC may rely on other legal grounds of processing to the extent permitted under applicable law.

Contact us

Jia Xu

Pharma and Healthcare Industry Leader, PwC China

Tel: +[86] (10) 6533 7734

March 2023

We welcome your comments

Contact us